Development of blood-based monitoring techniques in lymphatic malignancies

Recruiting

• Conditions: 10025320; ymphoide maligniteiten volgens WHO 2016 classificatie; lymphatic malignancies; 10025319

• Registration Number: NL-OMON47352
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

Diagnosed with a lymphoid malignancy as defined in the WHO classification 2016.

Exclusion Criteria

Patient is at inclusion also diagnosed with a solid-malignancy, such as breast cancer, colon carcinoma, melanoma or other solid malignancies that requires treatment.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study endpoint is the development of validated blood-based assays for<br /><br>monitoring disease status in patients with lymphoid neoplasms and correlation<br /><br>of blood-based assays with PET response during and after treatment. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>